Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (4)
Nature Communications (2)
Nature (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (5)
Amendments and Corrections (2)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Diseases
Genetics

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–7 of 7 results

Advanced filters: Author: Cody Coblentz Clear advanced filters

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Theodore P. Braun
Mariam Okhovat
Julia E. Maxson
Amendments and CorrectionsOpen Access16 Jun 2022
Nature Communications

Volume: 13, P: 1
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Acute Myeloid Leukemia (AML) develops following multiple mutations of differing impact. Here, the authors show that activating mutations of CSF3R co-operate with loss-of-function mutations of CEBPA to promote AML development through an enhancer-dependent mechanism.

Theodore P. Braun
Mariam Okhovat
Julia E. Maxson
ResearchOpen Access29 Nov 2019
Nature Communications

Volume: 10, P: 1-15
Functional genomic landscape of acute myeloid leukaemia

Analyses of samples from patients with acute myeloid leukaemia reveal that drug response is associated with mutational status and gene expression; the generated dataset provides a basis for future clinical and functional studies of this disease.

Jeffrey W. Tyner
Cristina E. Tognon
Brian J. Druker
Research17 Oct 2018
Nature

Volume: 562, P: 526-531
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development

Sarah A. Carratt
Garth L. Kong
Julia E. Maxson
Research09 Mar 2023
Leukemia

Volume: 37, P: 1141-1146
Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia

Sarah A. Carratt
Theodore P. Braun
Julia E. Maxson
Amendments and Corrections06 Jul 2022
Leukemia

Volume: 36, P: 2149
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia

Sarah A. Carratt
Theodore P. Braun
Julia E. Maxson
Research17 May 2021
Leukemia

Volume: 35, P: 3594-3599
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors

Theodore P. Braun
Joseph Estabrook
Julia E. Maxson
Research16 Dec 2022
Leukemia

Volume: 37, P: 478-487